RESUMEN
The prevalence of eating disorders has been increasing over the last 50 years. Binge eating disorder (BED) and bulimia nervosa (BN) are two typical disabling, costly and life-threatening eating disorders that substantially compromise the physical well-being of individuals while undermining their psychological functioning. The distressing and recurrent episodes of binge eating are commonly observed in both BED and BN; however, they diverge as BN often involves the adoption of inappropriate compensatory behaviors aimed at averting weight gain. Normal eating behavior is coordinated by a well-regulated trade-off between intestinal and central ingestive mechanism. Conversely, despite the fact that the etiology of BED and BN remains incompletely resolved, emerging evidence corroborates the notion that dysbiosis of gastrointestinal microbiome and its metabolites, alteration of gut-brain axis, as well as malfunctioning central circuitry regulating motivation, execution and reward all contribute to the pathology of binge eating. In this review, we aim to outline the current state of knowledge pertaining to the potential mechanisms through which each component of the gut-brain axis participates in binge eating behaviors, and provide insight for the development of microbiome-based therapeutic interventions that hold promise in ameliorating patients afflicted with binge eating disorders.
Asunto(s)
Trastorno por Atracón , Eje Cerebro-Intestino , Encéfalo , Disbiosis , Microbioma Gastrointestinal , Microbioma Gastrointestinal/fisiología , Humanos , Trastorno por Atracón/microbiología , Trastorno por Atracón/fisiopatología , Trastorno por Atracón/metabolismo , Eje Cerebro-Intestino/fisiología , Encéfalo/microbiología , Encéfalo/fisiopatología , Animales , Disbiosis/microbiología , Conducta AlimentariaRESUMEN
Binge eating is a central component of two clinical eating disorders: binge eating disorder and bulimia nervosa. However, the large treatment gap highlights the need to identify other strategies to decrease binge eating. Novel pharmacotherapies may be one such approach. Glucagon-like peptide-1 (GLP-1) is an intestinal and brain-derived neuroendocrine signal with a critical role in promoting glycemic control through its incretin effect. Additionally, the energy balance effects of GLP-1 are well-established; activation of the GLP-1 receptor (GLP-1R) reduces food intake and body weight. Aligned with these beneficial metabolic effects, there are GLP-1R agonists that are currently used for the treatment of diabetes and obesity. A growing body of literature suggests that GLP-1 may also play an important role in binge eating. Dysregulation of the endogenous GLP-1 system is associated with binge eating in non-human animal models, and GLP-1R agonists may be a promising approach to suppress the overconsumption that occurs during binge eating. Here, we briefly discuss the role of GLP-1 in normal energy intake and reward and then review the emerging evidence suggesting that disruptions to GLP-1 signaling are associated with binge eating. We also consider the potential utility of GLP-1-based pharmacotherapies for reducing binge eating behavior.
Asunto(s)
Péptido 1 Similar al Glucagón , Receptor del Péptido 1 Similar al Glucagón , Humanos , Péptido 1 Similar al Glucagón/metabolismo , Animales , Receptor del Péptido 1 Similar al Glucagón/agonistas , Receptor del Péptido 1 Similar al Glucagón/metabolismo , Trastorno por Atracón/tratamiento farmacológico , Trastorno por Atracón/metabolismo , Bulimia/metabolismo , Ingestión de Energía/fisiología , Metabolismo Energético/fisiologíaRESUMEN
OBJECTIVE: Binge-eating disorder is an eating disorder characterized by recurrent binge-eating episodes, during which individuals consume excessive amounts of highly palatable food (HPF) in a short time. This study investigates the intricate relationship between repeated binge-eating episode and the transcriptional regulation of two key genes, adenosine A2A receptor (A2AAR) and dopamine D2 receptor (D2R), in selected brain regions of rats. METHOD: Binge-like eating behavior on HPF was induced through the combination of food restrictions and frustration stress (15 min exposure to HPF without access to it) in female rats, compared to control rats subjected to only restriction or only stress or none of these two conditions. After chronic binge-eating episodes, nucleic acids were extracted from different brain regions, and gene expression levels were assessed through real-time quantitative PCR. The methylation pattern on genes' promoters was investigated using pyrosequencing. RESULTS: The analysis revealed A2AAR upregulation in the amygdala and in the ventral tegmental area (VTA), and D2R downregulation in the nucleus accumbens in binge-eating rats. Concurrently, site-specific DNA methylation alterations at gene promoters were identified in the VTA for A2AAR and in the amygdala and caudate putamen for D2R. DISCUSSION: The alterations on A2AAR and D2R genes regulation highlight the significance of epigenetic mechanisms in the etiology of binge-eating behavior, and underscore the potential for targeted therapeutic interventions, to prevent the development of this maladaptive feeding behavior. These findings provide valuable insights for future research in the field of eating disorders. PUBLIC SIGNIFICANCE: Using an animal model with face, construct, and predictive validity, in which cycles of food restriction and frustration stress evoke binge-eating behavior, we highlight the significance of epigenetic mechanisms on adenosine A2A receptor (A2AAR) and dopamine D2 receptor (D2R) genes regulation. They could represent new potential targets for the pharmacological management of eating disorders characterized by this maladaptive feeding behavior.
Asunto(s)
Trastorno por Atracón , Bulimia , Receptor de Adenosina A2A , Receptores de Dopamina D2 , Recompensa , Animales , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D2/genética , Femenino , Ratas , Receptor de Adenosina A2A/genética , Receptor de Adenosina A2A/metabolismo , Bulimia/metabolismo , Bulimia/genética , Trastorno por Atracón/genética , Trastorno por Atracón/metabolismo , Encéfalo/metabolismo , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Metilación de ADN , Área Tegmental Ventral/metabolismo , Conducta Alimentaria , Núcleo Accumbens/metabolismo , Ratas Sprague-DawleyRESUMEN
Binge eating is a characteristic symptom observed in obese individuals that is related to dysfunction of dopaminergic neurons (DNs). Intermittent administration of a high-fat diet (HFD) is reported to induce binge-like eating, but the underlying mechanisms remain unclear. We generated dopaminergic neuron specific IKKß deficient mice (KO) to examine the effects of inflammation in DNs on binge-like eating under inflammatory conditions associated with HFD. After administration of HFD for 4 weeks, mice were fasted for 24 h, and then the consumption of HFD was measured for 2 h. We also evaluated that the mRNA expressions of inflammatory cytokines, glial markers, and dopamine signaling-related genes in the ventral tegmental area (VTA) and striatum. Moreover, insulin was administered intraventricularly to assess downstream signaling. The consumption of HFD was significantly reduced, and the phosphorylation of AKT in the VTA was significantly increased in female KO compared to wild-type (WT) mice. Analyses of mRNA expressions revealed that DNs activity and inflammation in the VTA were significantly decreased in female KO mice. Thus, our data suggest that HFD-induced inflammation with glial cell activation in the VTA affects DNs function and causes abnormal eating behaviors accompanied by insulin resistance in the VTA of female mice.
Asunto(s)
Trastorno por Atracón , Insulinas , Animales , Trastorno por Atracón/metabolismo , Citocinas/metabolismo , Dieta Alta en Grasa , Dopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Femenino , Quinasa I-kappa B/metabolismo , Inflamación/metabolismo , Insulinas/metabolismo , Insulinas/farmacología , Ratones , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/metabolismo , Área Tegmental Ventral/metabolismoRESUMEN
Binge eating involves consumption of large amounts of food and a loss of control over the amount consumed. The incidence of binge eating disorder is higher in females than males, hinting at important sex differences in binge eating behavior, but the neural underpinnings of binge eating still remain unresolved. Recent work in male rats has shown that a history of binge-like palatable food intake suppresses hindbrain expression of preproglucagon (PPG), the precursor for glucagon-like peptide-1 (GLP-1). Given the roles of GLP-1 in reducing feeding and food reward, this could be a mechanism underlying binge-like eating in rodents. However, whether similar effects occur in female rats is unknown. Here, we tested the hypothesis that a history of binge-like palatable food intake in female rats would reduce PPG expression in the nucleus tractus solitarius (NTS), a key central site of GLP-1 production. Female rats given access to vegetable shortening every fourth day (4D) engaged in binge-like feeding, demonstrated by consuming significantly more shortening during the first hour of fat access compared to counterparts with ad libitum (AL) fat access. After several weeks of fat access under these schedules, PPG and GLP-1 receptor (GLP-1R) expression were measured in the NTS and ileum. Surprisingly, and in contrast to previous findings in male rats, there were no significant differences in expression of PPG or GLP-1R in either site in 4D versus AL rats, nor were there effects on plasma GLP-1 levels. These findings highlight key differences in the effects of binge-like intake on the central GLP-1 system in female compared to male rats.
Asunto(s)
Trastorno por Atracón , Péptido 1 Similar al Glucagón , Animales , Trastorno por Atracón/metabolismo , Ingestión de Alimentos , Femenino , Péptido 1 Similar al Glucagón/metabolismo , Masculino , Ratas , Ratas Sprague-Dawley , Núcleo Solitario/metabolismoRESUMEN
A considerable percentage of the population is affected by alcoholic liver disease (ALD). It is characterized by inflammatory signals from the liver and other organs, such as the intestine. The NLR family pyrin domain containing 6 (NLRP6) inflammasome complex is one of the most important inflammatory mediators. The aim of this study was to evaluate a novel mouse model for ALD characterized by 8-week chronic-plus-binge ethanol administration and to investigate the role of NLRP6 inflammasome for intestinal homeostasis and ALD progression using Nlrp6-/- mice. We showed that chronic-plus-binge ethanol administration triggers hepatic steatosis, injury, and neutrophil infiltration. Furthermore, we discovered significant changes of intestinal microbial communities, including increased relative abundances of bacteria within the phyla Bacteroidota and Campilobacterota, as well as reduced Firmicutes. In this ALD model, inhibiting NLRP6 signaling had no effect on liver steatosis or damage, but had a minor impact on intestinal homeostasis via affecting intestinal epithelium function and gut microbiota. Surprisingly, Nlrp6 loss resulted in significantly decreased hepatic immune cell infiltration. As a result, our novel mouse model encompasses several aspects of human ALD, such as intestinal dysbiosis. Interfering with NLRP6 inflammasome activity reduced hepatic immune cell recruitment, indicating a disease-aggravating role of NLRP6 during ALD.
Asunto(s)
Trastorno por Atracón/metabolismo , Trastorno por Atracón/patología , Progresión de la Enfermedad , Inflamasomas/metabolismo , Hepatopatías Alcohólicas/metabolismo , Hepatopatías Alcohólicas/patología , Receptores de Superficie Celular/metabolismo , Consumo de Bebidas Alcohólicas , Animales , Trastorno por Atracón/microbiología , Ciego/microbiología , Enfermedad Crónica , Modelos Animales de Enfermedad , Hígado Graso/complicaciones , Hígado Graso/patología , Microbioma Gastrointestinal , Mucosa Intestinal/patología , Hígado/lesiones , Hígado/patología , Hepatopatías Alcohólicas/microbiología , Ratones Endogámicos C57BL , Ratones Noqueados , Infiltración Neutrófila , Receptores de Superficie Celular/deficiencia , Transducción de SeñalRESUMEN
Food addiction (FA) is characterized by behavioral and neurochemical changes linked to loss of food intake control. Gut microbiota may influence appetite and food intake via endocrine and neural routes. The gut microbiota is known to impact homeostatic energy mechanisms, but its role in regulating the reward system is less certain. We show that the administration of Bacteroides uniformis CECT 7771 (B. uniformis) in a rat FA model impacts on the brain reward response, ameliorating binge eating and decreasing anxiety-like behavior. These effects are mediated, at least in part, by changes in the levels of dopamine, serotonin, and noradrenaline in the nucleus accumbens and in the expression of dopamine D1 and D2 receptors in the prefrontal cortex and intestine. B. uniformis reverses the fasting-induced microbiota changes and increases the abundance of species linked to healthy metabolotypes. Our data indicate that microbiota-based interventions might help to control compulsive overeating by modulating the reward response.
Asunto(s)
Ansiedad/metabolismo , Bacteroides/metabolismo , Trastorno por Atracón/metabolismo , Encéfalo/metabolismo , Microbioma Gastrointestinal/fisiología , Recompensa , Animales , Ansiedad/terapia , Bacteroides/aislamiento & purificación , Trastorno por Atracón/terapia , Humanos , Recién Nacido , Masculino , Microdiálisis/métodos , Ratas , Ratas Endogámicas WKYRESUMEN
Highly palatable foods and substance of abuse have intersecting neurobiological, metabolic and behavioral effects relevant for understanding vulnerability to conditions related to food (e.g., obesity, binge eating disorder) and drug (e.g., substance use disorder) misuse. Here, we review data from animal models, clinical populations and epidemiological evidence in behavioral, genetic, pathophysiologic and therapeutic domains. Results suggest that consumption of highly palatable food and drugs of abuse both impact and conversely are regulated by metabolic hormones and metabolic status. Palatable foods high in fat and/or sugar can elicit adaptation in brain reward and withdrawal circuitry akin to substances of abuse. Intake of or withdrawal from palatable food can impact behavioral sensitivity to drugs of abuse and vice versa. A robust literature suggests common substrates and roles for negative reinforcement, negative affect, negative urgency, and impulse control deficits, with both highly palatable foods and substances of abuse. Candidate genetic risk loci shared by obesity and alcohol use disorders have been identified in molecules classically associated with both metabolic and motivational functions. Finally, certain drugs may have overlapping therapeutic potential to treat obesity, diabetes, binge-related eating disorders and substance use disorders. Taken together, data are consistent with the hypotheses that compulsive food and substance use share overlapping, interacting substrates at neurobiological and metabolic levels and that motivated behavior associated with feeding or substance use might constitute vulnerability factors for one another. This article is part of the special issue on 'Vulnerabilities to Substance Abuse'.
Asunto(s)
Trastorno por Atracón/fisiopatología , Encéfalo/fisiopatología , Adicción a la Comida/fisiopatología , Obesidad/fisiopatología , Trastornos Relacionados con Sustancias/fisiopatología , Animales , Trastorno por Atracón/genética , Trastorno por Atracón/metabolismo , Encéfalo/metabolismo , Adicción a la Comida/genética , Adicción a la Comida/metabolismo , Predisposición Genética a la Enfermedad , Humanos , Obesidad/genética , Obesidad/metabolismo , Refuerzo en Psicología , Recompensa , Factores de Riesgo , Trastornos Relacionados con Sustancias/genética , Trastornos Relacionados con Sustancias/metabolismoRESUMEN
BACKGROUND: The genetics of binge-eating disorder (BED) is an emerging topic, with dopaminergic genes being implicated in its etiology due to the role that dopamine (DA) plays in food reward sensitivity and self-regulation of eating behavior. However, no study to date has examined if DA genes influence response to behavioral treatment of BED. OBJECTIVE: The primary objective of this study was to examine the ability of DA-associated polymorphisms to predict BED treatment response measured using binge frequency over 12 months. As secondary objectives, this study examined cross-sectional relationships between these polymorphisms and anthropometrics in women living with and without BED and obesity. METHODS: Women aged 18-64 years old were genotyped for the DA-related SNPs DRD2/ANKK1 Taq1A (rs1800497) and COMT (rs4680), as well as the DA-related uVNTRs DAT-1 (SLC6A3) and MAO-A. A multi-locus DA composite score was formed from these 4 polymorphisms using genotypes known to have a functional impact resulting in modified DA signaling. Binge frequency (Eating Disorder Examination - Interview) and body composition (Tanita BC-418) were assessed in a pre-post analysis to examine genetic predictors of treatment response in women living with obesity and BED. Secondary data analysis was conducted on a cross-sectional comparison of three groups of women enrolled in trial group treatment for BED: women living with obesity and BED (n = 72), obesity without BED (n = 27), and normal-weight without BED (n = 45). RESULTS: There were no significant genotype × time interactions related to anthropometrics or binge frequency for any individual DA genotypes, or to the composite score reflecting DA availability. At baseline, there were no significant between-group differences in frequencies of DA-related alleles, nor were there associations between genotypes and anthropometrics. CONCLUSIONS: Our study found no evidence to suggest that the DRD2/ANKK1 Taq1A, COMT, MAO-A, or DAT-1 polymorphisms are associated with response to behavioral intervention for BED as measured by changes in binge frequency. Future studies should examine a greater variety of dopaminergic polymorphisms, other candidate genes that target other neurotransmitter systems, as well as examine their impact on both behavioral and pharmacological-based treatment for BED.
Asunto(s)
Trastorno por Atracón/genética , Dopamina/genética , Polimorfismo Genético , Adolescente , Adulto , Trastorno por Atracón/metabolismo , Catecol O-Metiltransferasa/genética , Estudios Transversales , Femenino , Genotipo , Humanos , Persona de Mediana Edad , Monoaminooxidasa/genética , Proteínas Serina-Treonina Quinasas/genética , Receptores de Dopamina D2/genética , Adulto JovenRESUMEN
Maladaptive eating behavior is a growing public health problem and compulsively eating excessive food in a short time, or binge eating, is a key symptom of many eating disorders. In order to investigate the binge-like eating behavior in female rats, induced by intermittent food restrictions/refeeding and frustration stress, we analyzed for the first time the metabolic profile obtained from serum of rats, through nuclear magnetic resonance (NMR) spectroscopy. In this experimental protocol, rats were exposed to chow food restricting/refeeding and frustration stress manipulation. This stress procedure consists of 15 min exposure to the odor and sight of a familiar chocolate paste, without access to it, just before offering the palatable food. In this model, a "binge-eating episode" was considered the significantly higher palatable food consumption within 2 h in restricted and stressed rats (R + S) than in the other three experimental groups: rats with no food restriction and no stress (NR + NS), only stressed rats (NR + S) or only restricted rats (R + NS). Serum samples from these four different rat groups were collected. The statistical analysis of the 1 H NMR spectral profiles of the four sets of samples pointed to O- and N-acetyl glycoproteins as the main biomarkers for the discrimination of restriction effects. Other metabolites, such as threonine, glycine, glutamine, acetate, pyruvate and lactate, showed trends that may be useful to understand metabolic pathways involved in eating disorders. This study suggested that NMR-based metabolomics is a suitable approach to detect biomarkers related to binge-eating behavior.
Asunto(s)
Trastorno por Atracón/metabolismo , Espectroscopía de Resonancia Magnética/métodos , Metabolómica , Animales , Biomarcadores/sangre , Femenino , Lípidos/sangre , Sustancias Macromoleculares/sangre , Ratas , Ratas Sprague-DawleyRESUMEN
Binge eating disorder (BED) increasingly affects population, but the mechanisms of the disease and its biomarkers are not well characterized. Recently, plasma purines, pyrimidines, amino acid and nicotinamide metabolites profiling attracted attention in studies on pathology and biomarkers of mental disorders but has not been adequately studied in BED. Blood and plasma samples were taken from patients with adult obese with BED (n = 20) and control adult obese without BED (n = 17). Plasma samples were analyzed for nucleotides and amino acid concentrations with high-performance liquid chromatography-mass spectrometry. BED had a significantly (p < 0.05) lower uridine and hypoxanthine to creatinine ratio compared to the control group. Among the amino acids BED patients had significantly (p < 0.05) lower concentrations of glutamic acid, leucine, isoleucine and the whole branched-chain amino acids group, while the concentration of citrulline was increased. Among nicotinamide metabolites, 1-methylnicotinamide levels were significantly (p < 0.05) lower. This study highlights potential use of profiling nucleotide metabolite and amino acid pattern in BED patients that may provide information on mechanisms and potential biomarkers. However, further investigation in larger population is necessary to identify clinical correlates of the observed changes.
Asunto(s)
Aminoácidos/sangre , Trastorno por Atracón/sangre , Trastorno por Atracón/metabolismo , Nucleótidos/sangre , Nucleótidos/metabolismo , Obesidad/sangre , Obesidad/metabolismo , Adulto , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Binge eating disorder (BED) is known as the most common eating disorder with both psychosocial and biological factors involved. In this regard, there is a need to recognize probable disturbances in substances involved in food intake regulation in BED. In this study, we hypothesized that the levels of endocannabinoids, fatty acid amid hydrolase (FAAH) gene polymorphisms, and appetite regulatory substances are different in overweight and obese women with and without BED. A Binge Eating Scale was used to estimate the prevalence of BED in 180 women classified as overweight or obese. The levels of anandamide (AEA), 2-arachidonoylglycerol (2-AG), leptin, insulin, and orexin-A were measured by enzyme-linked immunosorbent assay kits. The subjects were genotyped for polymorphisms of FAAH gene using amplification refractory mutation system-polymerase chain reaction. Data were analyzed using SPSS software. About 41.6% (nâ¯=â¯75) of the subjects were diagnosed with BED. Women with BED exhibited significantly higher levels of AEA, 2-AG, leptin, and insulin compared to non-BED women (Pâ¯<â¯.05). Binary logistic regression analysis also showed that AEA, leptin, and insulin were the predictors of having BED after adjusting for body mass index (Pâ¯<â¯.05). In addition, the frequency of A allele of FAAH gene was higher in women with BED compared to women without BED; however, there were no significant differences between these 2 groups (Pâ¯=â¯.08). These results supported our hypothesis in the cases of AEA, 2-AG, leptin, and insulin but not orexin and FAAH gene polymorphisms. The findings of the current study provide further evidence concerning the role of these substances in BED.
Asunto(s)
Amidohidrolasas/genética , Trastorno por Atracón/genética , Trastorno por Atracón/metabolismo , Endocannabinoides/sangre , Adulto , Ácidos Araquidónicos/sangre , Índice de Masa Corporal , Estudios Transversales , Femenino , Genotipo , Glicéridos/sangre , Humanos , Insulina/sangre , Leptina/sangre , Obesidad/genética , Obesidad/metabolismo , Orexinas/sangre , Sobrepeso/genética , Sobrepeso/metabolismo , Polimorfismo Genético , Alcamidas Poliinsaturadas/sangreRESUMEN
PURPOSE OF REVIEW: The aim of this study was to highlight the recent advancements and future directions for potential use of a low carbohydrate ketogenic dietary approach to treat binge eating and ultraprocessed food addiction. Herein, we explore proposed mechanisms of why a diet low in refined carbohydrates, processed sugar and higher fat content may be helpful in alleviating symptoms. RECENT FINDINGS: Emerging evidence suggests there may be a metabolic role in development of maladaptive eating. These findings broaden our understanding of eating psychopathology causes. Ultraprocessed, refined or high glycemic index carbohydrates are a possible trigger mediating neurochemical responses similar to addiction. The carbohydrate-insulin model of obesity supports observations of these foods triggering abnormal blood sugar and insulin spikes subsequently leading to changes in metabolic and neurobiological signaling. This results in overeating symptoms and hunger exacerbation, which differs from observed effects of healthy fat consumption and lack of similar insulin spikes. As supported in recent case series, significantly reducing or abstaining from these addictive-like ultraprocessed foods and highly refined carbohydrates could be considered a treatment approach. SUMMARY: The current review highlights recent and pertinent evidence with respect to theoretical and practical application of low carbohydrate ketogenic therapeutic approaches for ultraprocessed food addiction and binge eating symptoms. VIDEO ABSTRACT:.
Asunto(s)
Trastorno por Atracón/dietoterapia , Dieta Baja en Carbohidratos , Dieta Cetogénica , Adicción a la Comida/dietoterapia , Trastorno por Atracón/complicaciones , Trastorno por Atracón/epidemiología , Trastorno por Atracón/metabolismo , Dieta Baja en Carbohidratos/métodos , Dieta Cetogénica/métodos , Carbohidratos de la Dieta/efectos adversos , Adicción a la Comida/complicaciones , Adicción a la Comida/epidemiología , Adicción a la Comida/metabolismo , Manipulación de Alimentos , Preferencias Alimentarias/psicología , Humanos , Insulina/metabolismo , Obesidad/dietoterapia , Obesidad/epidemiología , Obesidad/etiología , Obesidad/metabolismoRESUMEN
Binge eating behavior (BEB) is the most common condition among eating disorders. In animal models, binge eating behavior is defined as overconsumption in a brief time interval and it develops as a progressive increase in food intake along time. It is triggered by restricting food access to regular chow or to palatable food and is associated with dopamine release from the ventral tegmental area to the nucleus accumbens. The dopamine system, exhibits day-night patterns, suggesting regulation by the circadian system. This study explored in rats the differential contribution of restricted food access to chow and sucrose for developing BEB, it explored whether BEB exhibits a day-night pattern, and whether behavioral changes are associated with the number of tyrosine hydroxylase (TH) positive cells in the ventral tegmental area, with the expression of dopamine 1 receptors (D1) and glutamate receptor subunit 1 receptors (GLUR1) in the nucleus accumbens. Present data indicate that under conditions of restricted access binge eating is developed for chow or sucrose. Both types of binge eating were independent of each other and exhibited a day-night pattern with increased intensity during the active phase (night). Binge eating was preceded by anticipatory activation, except when restricted food access was given during the day. Increased optical density for D1 receptors was found after exposure to the combination of restricted food access and sucrose. No association was observed between binge eating and the number of positive cells to TH in the ventral tegmental area, nor for GLUR1 in the nucleus accumbens. Present results point out the importance of time schedules to eat, highlighting an increased vulnerability to develop binge eating during the active phase. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Asunto(s)
Bulimia/metabolismo , Ritmo Circadiano/fisiología , Sacarosa/metabolismo , Animales , Trastorno por Atracón/metabolismo , Trastorno por Atracón/fisiopatología , Encéfalo/efectos de los fármacos , Bulimia/fisiopatología , Ingestión de Alimentos/fisiología , Conducta Alimentaria/fisiología , Alimentos , Preferencias Alimentarias/fisiología , Masculino , Núcleo Accumbens/efectos de los fármacos , Ratas , Ratas Wistar , Sacarosa/farmacología , Área Tegmental Ventral/efectos de los fármacosAsunto(s)
Trastorno por Atracón/fisiopatología , Dopamina/metabolismo , Obesidad , Enfermedad de Parkinson/tratamiento farmacológico , Trastorno por Atracón/complicaciones , Trastorno por Atracón/metabolismo , Ansia , Dopaminérgicos/uso terapéutico , Agonistas de Dopamina/uso terapéutico , Adicción a la Comida , Humanos , Levodopa/uso terapéutico , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/fisiopatologíaRESUMEN
Accumulated data from clinical and preclinical studies suggest that, in drug addiction and states of overeating, such as obesity and binge eating disorder (BED), there is an imbalance in circuits that are critical for motivation, reward saliency, executive function, and self-control. Central to these pathologies and the extensive topic of this Review are the aberrations in dopamine (DA) and glutamate (Glu) within the mesolimbic pathway. Group I metabotropic glutamate receptors (mGlus) are highly expressed in the mesolimbic pathway and are poised in key positions to modulate disruptions in synaptic plasticity and neurotransmitter release observed in drug addiction, obesity, and BED. The use of allosteric modulators of group I mGlus has been studied in drug addiction, as they offer several advantages over traditional orthosteric agents. However, they have yet to be studied in obesity or BED. With the substantial overlap between the neurocircuitry involved in drug addiction and eating disorders, group I mGlus may also provide novel targets for obesity and BED.
Asunto(s)
Trastorno por Atracón/metabolismo , Neuronas Dopaminérgicas/metabolismo , Red Nerviosa/metabolismo , Obesidad/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Recompensa , Trastornos Relacionados con Sustancias/metabolismo , Animales , Dopamina/metabolismo , HumanosRESUMEN
Binge-eating disorder (BED) is the most common eating disorder, characterized by rapid, recurrent overconsumption of highly palatable food in a short time frame. BED shares an overlapping behavioral phenotype with obesity, which is also linked to the overconsumption of highly palatable foods. The reinforcing properties of highly palatable foods are mediated by the nucleus accumbens (NAc) and the ventral tegmental area (VTA), which have been implicated in the overconsumption behavior observed in BED and obesity. A potential regulator of binge-type eating behavior is the G protein-coupled receptor neuromedin U receptor 2 (NMUR2). Previous research demonstrated that NMUR2 knockdown potentiates binge-type consumption of high-fat food. We correlated binge-type consumption across a spectrum of fat and carbohydrate mixtures with synaptosomal NMUR2 protein expression in the NAc and VTA of rats. Synaptosomal NMUR2 protein in the NAc demonstrated a strong positive correlation with binge intake of a "lower"-fat (higher carbohydrate) mixture, whereas synaptosomal NMUR2 protein in the VTA demonstrated a strong negative correlation with binge intake of an "extreme" high-fat (0% carbohydrate) mixture. Taken together, these data suggest that NMUR2 may differentially regulate binge-type eating within the NAc and the VTA.
Asunto(s)
Trastorno por Atracón/metabolismo , Bulimia/metabolismo , Conducta Alimentaria/fisiología , Neuropéptidos/metabolismo , Núcleo Accumbens/metabolismo , Receptores de Neurotransmisores/metabolismo , Área Tegmental Ventral/metabolismo , Animales , Trastorno por Atracón/psicología , Bulimia/psicología , Carbohidratos de la Dieta/administración & dosificación , Grasas de la Dieta/administración & dosificación , Ingestión de Alimentos/psicología , Ingestión de Energía/fisiología , Conducta Alimentaria/psicología , Masculino , Obesidad/psicología , Ratas Sprague-DawleyRESUMEN
Binge eating disorder (BED) is characterized by recurrent episodes of eating an excessive amount of food over a discrete time period, while feeling a loss of control over one's eating. Although stress is one of the most commonly reported triggers of binge eating in individuals with BED, there has been little work examining the stress response specifically in individuals with the disorder. In this review, we examine what is known about how individuals with BED respond to acute stressors. A systematic literature search identified 14 relevant articles that report on the effects of experimentally induced stress on objective measures. Dependent measures that have been examined include changes in the levels of hormones such as cortisol and ghrelin, cardiovascular function, ad libitum food intake and eating rate. In this review, we describe the published findings and discuss their implications in the context of the wider literature. Overall, we found partial evidence that BED is associated with a heightened response to stress. Given the inconsistencies between studies, we suggest that reported differences between individuals with and without BED might be driven by factors that are correlated with, but not specific to, BED. We suggest that two priorities for this research area are to identify factors that modulate the stress response in individuals with BED, and to address the underrepresentation of males in this literature.
Asunto(s)
Trastorno por Atracón/metabolismo , Trastorno por Atracón/psicología , Encéfalo/metabolismo , Estrés Psicológico/metabolismo , Estrés Psicológico/psicología , Enfermedad Aguda , Hormona Adrenocorticotrópica/metabolismo , Humanos , Hidrocortisona/metabolismoRESUMEN
OBJECTIVE: Binge-eating episodes are recurrent and are defining features of several eating disorders. Thus binge-eating episodes might influence eating disorder development of which exact underlying mechanisms are still largely unknown. METHODS: Here we focused on the transcriptional regulation of the endocannabinoid system, a potent regulator of feeding behavior, in relevant rat brain regions, using a rat model in which a history of intermittent food restriction and a frustration stress induce binge-like palatable food consumption. RESULTS: We observed a selective down-regulation of fatty acid amide hydrolase (faah) gene expression in the hypothalamus of rats showing the binge-eating behavior with a consistent reduction in histone 3 acetylation at lysine 4 of the gene promoter. No relevant changes were detected for any other endocannabinoid system components in any brain regions under study, as well as for the other epigenetic mechanisms investigated (DNA methylation and histone 3 lysine 27 methylation) at the faah gene promoter. DISCUSSION: Our findings suggest that faah transcriptional regulation is a potential biomarker of binge-eating episodes, with a relevant role in the homeostatic regulation of food intake.
Asunto(s)
Amidohidrolasas , Trastorno por Atracón , Endocannabinoides , Hipotálamo , Amidohidrolasas/genética , Amidohidrolasas/metabolismo , Animales , Trastorno por Atracón/genética , Trastorno por Atracón/metabolismo , Biomarcadores , Bulimia , Conducta Alimentaria , Humanos , Hipotálamo/fisiología , Masculino , RatasRESUMEN
Multiple laboratories have shown that the stimulation of µ-opioid receptors in the nucleus accumbens (NAcc) powerfully increases intake of palatable and high-fat diets. Separate studies have demonstrated that serotonin agonists advance satiety processes, and several serotonin-targeting agents have been prescribed to promote weight loss. However, it is unknown if serotonin signaling can modulate the increased feeding elicited by activation of NAcc µ-opioid receptors. These experiments assessed the effects of systemic treatments with the serotonin agonists d-fenfluramine and lorcaserin on the binge-like feeding induced by µ-opioid receptor stimulation of the NAcc in Sprague-Dawley rats. Consistent with previous reports, stimulation of NAcc µ-opioid receptors (with 0.025 µg/0.5 µl/side DAMGO) significantly increased consumption of high-fat vegetable shortening, and systemic treatment with d-fenfluramine and lorcaserin dose-dependently decreased intake. Interestingly, d-fenfluramine and lorcaserin reversed the binge-like feeding observed following stimulation of NAcc µ-opioid receptors. Both serotonergic drugs also attenuated the increases of ambulation observed following administration of DAMGO in the NAcc. These data demonstrate that serotonergic anorectics, in addition to their known role in advancing satiety processes during normal feeding, can also inhibit the binge-like feeding that is elicited by activation of µ-opioid receptors within the ventral striatum.